Pharmaceuticals Companies By Shares Outstanding

Shares Outstanding
Shares OutstandingEfficiencyMarket RiskExp Return
1IDCN Indocan Resources
7.41 B
 0.00 
 0.00 
 0.00 
2PFE Pfizer Inc
5.67 B
 0.12 
 1.32 
 0.16 
3FITX Creative Edge Nutrit
4.75 B
 0.00 
 0.00 
 0.00 
4NVO Novo Nordisk AS
3.38 B
 0.00 
 2.40 
(0.01)
5TAK Takeda Pharmaceutical Co
3.17 B
 0.16 
 1.24 
 0.20 
6AZN AstraZeneca PLC ADR
3.1 B
 0.01 
 1.18 
 0.01 
7SLNX Solanbridge Group
2.61 B
(0.13)
 12.91 
(1.67)
8MRK Merck Company
2.53 B
(0.08)
 1.79 
(0.15)
9SNY Sanofi ADR
2.51 B
 0.22 
 1.42 
 0.31 
10JNJ Johnson Johnson
2.41 B
 0.20 
 1.09 
 0.22 
11GSK GlaxoSmithKline PLC ADR
2.04 B
 0.09 
 1.33 
 0.12 
12BMY Bristol Myers Squibb
2.03 B
 0.15 
 2.15 
 0.31 
13NVS Novartis AG ADR
2.02 B
 0.15 
 1.08 
 0.17 
14EAPH Easton Pharmaceutica
1.34 B
 0.00 
 0.00 
 0.00 
15VTRS Viatris
1.19 B
 0.15 
 1.86 
 0.28 
16TEVA Teva Pharma Industries
1.13 B
 0.05 
 2.10 
 0.10 
17ZOM Zomedica Pharmaceuticals Corp
997.95 M
(0.05)
 3.56 
(0.17)
18ADVT Advantis Corp
978.47 M
(0.13)
 12.91 
(1.67)
19LLY Eli Lilly and
900.43 M
 0.05 
 2.36 
 0.12 
20TLRY Tilray Inc
842.96 M
 0.02 
 3.26 
 0.06 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.